Menu

Amryt Pharma plc AMYT

Full chart Compare
Set alert

Price alert · AMYT

All alert types
14.70 +14.70

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Gross Profit & Other Income: $59.93MGross Profit & Other Income → Net Income: $1.00MGross Profit & Other Income → Selling, General & Admin: $92.00MGross Profit & Other Income → Research & Development: $37.73MGross Profit & Other Income → Other Operating Expenses: $25.29MGross Profit & Other Income → Interest Expense: $27.91MIncome Tax Benefit → Gross Profit & Other Income: $7.56MGross Profit → Gross Profit & Other Income: $116.42MRevenue → Gross Profit: $116.42MRevenue → Cost of Revenue: $106.12MOther Income$59.93MIncome Tax Benefit$7.56MGross Profit$116.42MCost of Revenue$106.12MGross Profit & Other Income$183.92MNet Income$1.00MSelling, General & Admin$92.00MResearch & Development$37.73MOther Operating Expenses$25.29MInterest Expense$27.91MRevenue$222.54M

Latest period ending Dec 31, 2021 · select a line to chart its full history

AMYT annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
222.54M182.61M58.12M17.09M
116.42M63.58M19.39M10.83M
-38.59M-46.46M-50.48M-18.04M
1.00M-104.53M-63.00M-30.49M
AMYT annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
113.03M118.80M67.23M11.23M
815.53M536.59M527.10M80.83M
456.77M470.45M395.26M84.53M
199.18M188.39M178.47M19.01M
358.76M66.14M131.83M-3.70M
AMYT annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
15.54M26.89M-37.47M-15.45M
106.40M-2.38M24.43M-229.00K
-125.43M26.03M65.94M3.27M
-1.54M-2.47M-652.00K-235.00K
-5.77M51.57M56.00M-13.19M